Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccine.Sjoerd H. van der Burg, Cornelis J.M. Melief, Cornelis J.�H. van de Velde et al.|PubMed|2002Cited by 91
Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancerSjoerd H. van der Burg, Rienk Offringa, Karin de Cock et al.|European Journal of Immunology|2001Cited by 60
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patientsAnand G. Menon, Cornelis J.�H. van de Velde, Cornelis J.M. Melief et al.|Cancer Gene Therapy|2003Cited by 49